Advertisement
Screener

AXSOME THERAPEUTICS, INC. (AXSM) Debt / Equity

AXSOME THERAPEUTICS, INC. (AXSM) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio 2.26.
  • 2026-03-31: Debt/Equity Ratio 3.44.
  • 2025-12-31: Debt/Equity Ratio 2.13.
  • 2025-09-30: Debt/Equity Ratio 2.55.

Complete source-backed debt/equity ratio history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-302.26
2026-03-313.44
2025-12-312.13
2025-09-302.55
2025-06-302.57
2024-12-313.17
2020-06-300.13
2020-03-310.13
2019-12-310.11
2019-09-302.9
2019-06-300.81
2019-03-311.11
2018-12-317.37
2018-09-3010.4
2018-06-301.21
2018-03-310.73
2017-12-310.59
2017-09-300.6
2017-06-300.44
2017-03-310.34
2016-12-310.45

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-312.13
2024-12-313.17
2019-12-310.11
2018-12-317.37
2017-12-310.59
2016-12-310.45

Similar stocks

Stock NameCountryMarket CapPE Ratio
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41